BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2348877)

  • 1. EPO--one year later. Fighting anemia in the courtroom.
    Riley JB; Pristave RJ
    Nephrol News Issues; 1990 May; 4(5):27. PubMed ID: 2348877
    [No Abstract]   [Full Text] [Related]  

  • 2. EPO--one year later. Effects of EPO on nutritional status in CRF.
    Schiro KB
    Nephrol News Issues; 1990 May; 4(5):26, 34. PubMed ID: 2348876
    [No Abstract]   [Full Text] [Related]  

  • 3. EPO (epoetin) approval stirs cost concern in Congress.
    Wagner M
    Mod Healthc; 1989 Jun; 19(23):4. PubMed ID: 10293460
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report.
    Adamson W; Egrie JC; Browne JK; Downing MR; Eschbach W
    Behring Inst Mitt; 1988 Aug; (83):188-92. PubMed ID: 3071336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EPO--one year later. The challenges for the social worker.
    Antonoff A
    Nephrol News Issues; 1990 May; 4(5):24, 29. PubMed ID: 2348875
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia.
    Fujita Y; Inoue S; Horiguchi S; Kuki A
    Miner Electrolyte Metab; 1995; 21(1-3):50-4. PubMed ID: 7565462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin and chronic renal failure.
    Drüeke T; Zins B; Naret C; Casadevall N; Goureau Y; Bererhi L; Zingraff J; Delons S; Kreis H; Varet B
    Nouv Rev Fr Hematol (1978); 1989; 31(2):97-8. PubMed ID: 2771635
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic occult intra-alveolar hemorrhage: a rare cause of failure to respond to erythropoietin.
    Conlon PJ; O'Neill S; O'Neill G; Kelly F; Donohoe J
    Clin Nephrol; 1994 Feb; 41(2):83-5. PubMed ID: 8004833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of renal anemia using synthetic human erythropoietin].
    Blumberg A; Zehnder C
    Ther Umsch; 1988 Dec; 45(12):895-9. PubMed ID: 3065970
    [No Abstract]   [Full Text] [Related]  

  • 11. [Erythropoietin: its biological properties and clinical use].
    Ermolenko VM; Nikolaev AIu
    Ter Arkh; 1990; 62(11):141-5. PubMed ID: 2094979
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolution of recombinant human erythropoietin usage in clinical practice in the United States. Is there an optimal way to use rHuEPO?
    Besarab A; McCrea JB
    ASAIO J; 1993; 39(1):11-8. PubMed ID: 8439674
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of the anaemia of chronic renal failure with recombinant erythropoietin.
    Adamson JW; Eschbach JW
    Q J Med; 1989 Dec; 73(272):1093-101. PubMed ID: 2694210
    [No Abstract]   [Full Text] [Related]  

  • 14. Does correction of anemia with recombinant human erythropoietin accelerate the progression of renal insufficiency?
    Lim VS
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):26-7. PubMed ID: 2356366
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythropoietin for anemia.
    Med Lett Drugs Ther; 1989 Sep; 31(801):85-6. PubMed ID: 2671624
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
    Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
    An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant erythropoietin therapy in renal and nonrenal anemia.
    Erslev AJ
    West J Med; 1992 Aug; 157(2):195-6. PubMed ID: 1441490
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of the anaemia of end-stage renal disease with recombinant human erythropoietin.
    Verbeelen D; Hauglustaine D; Sennesael J
    Neth J Med; 1988 Aug; 33(1-2):60-7. PubMed ID: 3247012
    [No Abstract]   [Full Text] [Related]  

  • 19. r-HuEPO treatment of anemia associated with multiple myeloma and ESRD.
    Van der Niepen P; Sennesael J; Verbeelen D
    Clin Nephrol; 1993 Feb; 39(2):113. PubMed ID: 8448915
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of renal anemia, 1960-1990.
    Koch KM; Frei U
    Adv Nephrol Necker Hosp; 1991; 20():19-30. PubMed ID: 2063711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.